Wei‐jie Guan
Impact in
- Infectious Diseases top 0.5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Oncology top 0.5%
- COVID-19 and healthcare impacts
Papers in
-
- Cystic Fibrosis Research Advances 49
- Neonatal Respiratory Health Research 33
- Chronic Obstructive Pulmonary Disease (COPD) Research 28
- Respiratory and Cough-Related Research 26
- Tracheal and airway disorders 23
- Physiology 38
- Asthma and respiratory diseases 34
- Co-authors
- Nanshan Zhong (75 shared papers)Wenhua Liang (5 shared papers)Hengrui Liang (3 shared papers)Jianxing He (7 shared papers)Shiyue Li (14 shared papers)Caichen Li (2 shared papers)Ruchong Chen (3 shared papers)Wei Wang (4 shared papers)
- Journals
- CHEST Journal (9 papers)Respirology (6 papers)PLoS ONE (6 papers)Respiratory Care (4 papers)International Journal of COPD (4 papers)
- Partner nations
- ChinaSingaporeUnited States
In The Last Decade
Wei‐jie Guan
150 papers receiving 7.6k citations
Wei‐jie Guan's Hit Papers
Peers
Comparison fields: 5 of 173
- Infectious Diseases 2.6k
- Oncology 2.8k
- Health, Toxicology and Mutagenesis 820
- Pulmonary and Respiratory Medicine 1.9k
- Neurology 746
Countries citing papers authored by Wei‐jie Guan
This map shows the geographic impact of Wei‐jie Guan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐jie Guan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐jie Guan more than expected).
Fields of papers citing papers by Wei‐jie Guan
This network shows the impact of papers produced by Wei‐jie Guan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐jie Guan. The network helps show where Wei‐jie Guan may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei‐jie Guan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 163 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China Hit paper breakdown → | 2020 | 2867 |
| 2 | Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19 Hit paper breakdown → | 2020 | 829 |
| 3 | Impact of air pollution on the burden of chronic respiratory diseases in China: time for urgent action Hit paper breakdown → | 2016 | 708 |
| 4 | Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial Hit paper breakdown → | 2020 | 338 |
| 5 | 2020 | 269 | |
| 6 | 2021 | 163 | |
| 7 | 2021 | 148 | |
| 8 | 2016 | 87 | |
| 9 | 2017 | 85 | |
| 10 | 2015 | 73 | |
| 11 | 2020 | 60 | |
| 12 | 2018 | 60 | |
| 13 | 2019 | 59 | |
| 14 | 2015 | 57 | |
| 15 | 2023 | 53 | |
| 16 | 2017 | 51 | |
| 17 | 2016 | 46 | |
| 18 | 2016 | 46 | |
| 19 | 2015 | 46 | |
| 20 | 2018 | 45 |
About Wei‐jie Guan
Wei‐jie Guan is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Epidemiology, Infectious Diseases and Immunology and Allergy, having authored 163 papers that have together received 7.7k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (49 papers), Asthma and respiratory diseases (34 papers), Neonatal Respiratory Health Research (33 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (28 papers), Respiratory and Cough-Related Research (26 papers), Tracheal and airway disorders (23 papers), Allergic Rhinitis and Sensitization (19 papers) and Pediatric health and respiratory diseases (17 papers). The work is most often cited by research in Infectious Diseases (2.6k citations), Oncology (2.8k citations), Health, Toxicology and Mutagenesis (820 citations), Pulmonary and Respiratory Medicine (1.9k citations) and Neurology (746 citations). Wei‐jie Guan has collaborated with scholars based in China, Singapore and United States. Frequent co-authors include Nanshan Zhong, Wenhua Liang, Hengrui Liang, Jianxing He, Shiyue Li, Caichen Li, Ruchong Chen, Wei Wang, Ke Xu and Qing Ai. Their work appears in journals such as CHEST Journal, Respirology, PLoS ONE, Respiratory Care and International Journal of COPD.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.